IOF and ESCEO are delighted to welcome Amgen and UCB to the ESCEO-IOF Pre-Competitive Consortium on Osteoporosis and Bone Health (PRECCO).

The Consortium, created to support the five-year partnership signed between ESCEO and the World Health Organization (WHO) to improve the management of osteoporosis, involves a diverse range of stakeholders who all place patients at the center of their priorities, independently of their immediate strategy, in terms of content and timeline.  With the addition of Amgen and UCB, the PRECCO now counts 25 partners which are active in the screening, diagnosis, prevention, treatment, and monitoring of osteoporosis.

ESCEO and IOF are very proud of this partnership, which will serve to prioritize osteoporosis on the WHO agenda. 

READ MORE

A thank you to all PRECCO members (August 2024)